5-Aza-2'-deoxycytidine (Decitabine) (ab120842)

Overview

  • Product name5-Aza-2'-deoxycytidine (Decitabine)
  • Description
    Potent DNMT1 inhibitor. Induces DNA hypomethylation.
  • Alternative names
    • 5-AzadCyD
    • Dacogen
    • Decitabine
    • NSC 127716
  • Biological descriptionPotent DNA methyltransferase 1 (DNMT1) inhibitor (IC50 = 0.2 μM). Incorporated into DNA, inhibits DNMT1 activity to induce DNA hypomethylation. Interferes with protein synthesis. Shows antimetabolic and anticancer activities in vitro. Active in vivo.
  • Purity> 99%

Properties

    References for 5-Aza-2'-deoxycytidine (Decitabine) (ab120842)

    This product has been referenced in:
    • Shin DY  et al. Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation. Int J Oncol 41:910-8 (2012). Read more (PubMed: 22767021) »
    • Rodríguez-Reyes R & Morales-Ramírez P The in vivo induction of sister chromatid exchange by the demethylating agent 5-aza-2'-deoxycytidine. Mutagenesis 26:551-4 (2011). Read more (PubMed: 21454325) »
    • Liu QY  et al. Decitabine, independent of apoptosis, exerts its cytotoxic effects on cell growth in melanoma cells. Environ Toxicol Pharmacol 32:423-9 (2011). Read more (PubMed: 22004962) »
    • Cortvrindt R  et al. 5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma. Br J Cancer 56:261-5 (1987). Read more (PubMed: 2444244) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120842.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"